Biogen appoints Jane Grogan as Executive Vice President

Biogen announced the appointment of Jane Grogan, as Executive Vice President, Head of Research effective 2 October. Grogan will be a member of Biogen’s Executive Committee reporting to Christopher A. Viehbacher, President and CEO. Jane Grogan brings nearly two decades of experience leading biotech research, including fifteen years with Genentech. Grogan most recently served as the Chief Scientific Officer at Graphite Bio, a cell and gene editing company. Prior to this, she served as Chief Scientific Officer at ArsenalBio, a privately held programmable T cell therapy company, responsible for research, discovery and preclinical pipeline, including development for the company’s first product candidate.